Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.
Each issue contains a series of timely in-depth/mini reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Anna Lisa Iorio, Martina da Ros, Ornella Fantappiè, Maurizio Lucchesi, Ludovica Facchini, Alessia Stival, Sabrina Becciani, Milena Guidi, Claudio Favre, Maurizio de Martino, Lorenzo Genitori and Iacopo Sardi
Evgenii S. Mozhaitsev, Alexandra L. Zakharenko, Evgeniy V. Suslov*, Dina V. Korchagina, Olga D. Zakharova, Inna A. Vasil'eva, Arina A. Chepanova, Ellena Black, Jinal Patel, Raina Chand, Jóhannes Reynisson, Ivanhoe K.H. Leung, Konstantin P. Volcho, Nariman F. Salakhutdinov and Olga I. Lavrik
Prof. Michelle Prudhomme holds the position of Emeritus Professor at the Blaise Pascal University of Clermont-Ferrand, France. She was awarded Doctor-Engineer degree at the University of Caen France where her research focused on the synthesis of sulfur compounds. Then she received her Ph.D. Degree at the University of Clermont-Ferrand, France, after works on antibiotics. She developed projects related to drug design and discovery of cytotoxic compounds. She has authored or co-authored 108 research and review articles and and 6 patents.
Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.